Completion of Placement
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Funds raised will be allocated towards commercial expansion, technology development, and working capital needs. A general meeting will be held to seek shareholder approval for the second tranche of shares expected in early August.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Control Bionics
- Pause in Trading
- Commercial Momentum Presentation
- German Statutory Reimbursement Listing for NeuroNode
- Joint venture with NextLevel Assistive Technology
- Half Yearly Report and Accounts
Later from Control Bionics
- Commercial momentum builds across both platform pillars
- US FDA Registration and Device Listing for NeuroStrip
- NeuroStrip secures MHRA registration
- Medicare Billing Code Secured for NextLevel Speech Devices
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics